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An expression and mutagenesis system for the E. coli Class II fructose-l ,6-bisphosphate aldolase has been created by modification of the vector 
pKfda (B&hem. J. 257 (1989) 529-534). Large amounts of Class II aldolase (about 1 g/l in crude extracts), with properties consistent with those 
previously reported for the naturally occurring enzyme (B&hem. J. 169 (1978) 6333641) are obtained. The enzyme contains 2 zinc ions per enzyme 
dimer. We have investigated the nature of the zinc-binding site of the enzyme by site-directed mutagenesis. His-108, His-l 11, Cys-112 and His-142 
were identified as possible zinc-binding ligands by sequence alignments and comparisons with other known zinc-containing enzymes. Mutation 
of these residues identified His-108 and His-l 11 as two of the ligands directly responsible for the tight binding of zinc. Mutation of the other two 
residues results in only a small effect on the amount of zinc bound per monomer and a corresponding change in specific activity. These residues 
are, therefore, unlikely to be directly involved in zinc binding, but may be indirectly involved in some manner in the zinc-binding environment. 
Aldolase; Zinc binding; Protein engineering 
1. INTRODUCTION 
Fructose-l ,6_bisphosphate aldolase (FBP-aldolase) 
catalyses the reversible aldol cleavage of fructose 1,6- 
bisphosphate into glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate. Two classes of this en- 
zyme, designated Class I and Class II, are recognised 
based on their catalytic and structural properties [ 1,2]. 
The catalytic mechanism of the Class I aldolases has 
been extensively studied [3,4]. The reaction proceeds via 
a carbanion intermediate which is stabilised by a pro- 
tonated Schiff base formed between the substrate C-2 
carbonyl and the N6-amino group of an essential lysine 
residue in the active site. On the other hand, the Class 
II aldolases utilise a divalent metal ion in an apparently 
similar catalytic mechanism [5]. 
X-ray structures of the Class I fructose-1,6-bis- 
phosphate aldolases from several sources [&lo], and 
the phosphogluconate aldolase from Pseudomonas pu- 
ridu [ 11,121 have been determined. The Class I aldolases 
are, in general, tetramers of molecular weight around 
160,000 Da. The molecular architecture of these en- 
zymes is that of an eight-stranded a//l barrel [13]. 
In contrast to the wealth of structural information 
available for the Class I aldolases, comparatively little 
is known about the Class II enzymes. They are dimers 
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of molecular weight around 80,000 Da and contain 2 
zinc atoms per dimer, but no detailed structural infor- 
mation is available for any Class II aldolase. Unlike the 
Class I enzymes, the Class II aldolases do not utilise 
Schiff base formation in catalysis; instead, the zinc 
atoms perform the essential catalytic role [14]. In this 
paper we describe the overexpression, purification and 
characterisation of the wild-type Class II aldolase from 
E. co/i. In addition, by site-directed mutagenesis of his- 
tidine and cysteine residues, the identity of two of the 
zinc-binding ligands of the protein are determined and 
the role of a further histidine and cysteine residue con- 
served in various Class II aldolases has been investi- 
gated. 
2. EXPERIMENTAL 
2.1. Materials 
[%]dATP-aS triethylammonium salt (400 Ci/mmol) for DNA se- 
quencing was supplied by Amersham International. The mixture of 
glycerol-3-phosphate d hydrogenase and triose phosphate isomerase 
for the assay of aldolase and calf intestinal alkaline phosphatase were 
obtained from the Boehringer Mannheim GmbH, Germany. Restric- 
tion enzymes, T4 DNA ligase and T4 polynucleotide kinase were from 
Pharmacia. Buffers were treated by passage through a column of 
Chelating resin (Sigma Chemical Co.) whenever metal-free buffers 
were required. The plasmid pKfda was as described by Alefounder et 
al. [15], and was kindly obtained from Prof. R.N. Perham (University 
of Cambridge). 
E. coli strain TGl [K12, d(luc-pro), sup E, thi, hsd D5, /F’ tra D36, 
pro A’B’, luc I“, lac Z dMl5] was from Amersham International. E. 
coli strain HB2151 [K12, ara, d(lac-pro), sup E, thi, IF pro A’B’, lac 
14, lac Z dM15] was a gift from Dr G. Wmter, MRC Laboratory of 
Molecular Biology, Cambridge. E coli strain JM2087 [A(his grid), Aluc, 
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ara D, ./da. pts F. pts M, rpsL] was as previously described [16] and 
was a gift from Dr M.C. Jones-Mortimer (University of Cambridge). 
2.2. Site-directed mutagenesis, DNA sequencrng undplasmid construc- 
lion 
Site-directed mutagenesis was carried out on M 13fda or M 13fda2 
(see below). Mutants were constructed using the phosphorothioate 
method [ 171. Putative mutants were screened directly by dideoxy se- 
quencing. The mutated gene was resequenced to ensure that no spuri- 
ous mutations had been introduced. Plasmid and bacteriophage RF 
DNA was prepared as described by Maniatis et al. [18]. The mutated 
gene was isolated by restricting bacteriophage RF DNA with EcoRI 
and HindHI, and thefdu gene fragment was subcloned into the expres- 
sion vector pKK223-3 restricted with the same enzymes. 
2.3 Construction of the expressronlmuragenesu system 
The construction of the expression vector pKfda2 is summarised in 
Fig. 1. The 1139 bp EcoRIIBumHI fragment from pKfda [ 151 contain- 
ing the fda gene was subcloned into bacteriophage Ml3mpl9. Site- 
directed mutagenesis of the resulting bacteriophage (Ml3fda) was 
used to alter the codon for Glu-308 from GAA to GAG, thus destroy- 
ing a Hind111 site found within the gene. The resultant recombinant 
bacteriophage was designated Ml3fda2. Subsequent mutations were 
introduced into M 13fda2 as described above. Thefda gene was excised 
from M13fda2 on a 1169 bp EcoRIlHindIIl fragment and ligated 
directtonally into the expression vector pKK223-3 previously cut with 
EcoRI and Hind111 to yield pKfda2 (Fig. 1). 
E. coli strain KM3, a lac I4 andfda- strain was constructed by first 
converting strain JM2087 cfdu-) mto a proline auxotroph (strain 
KMl) by ampicillin enrichment [19] and then making the strain resis- 
tant to nalidixic acid (strain KM2) by selecting for growth on nalidixic 
acid containing (20 @ml) agar plates. Finally. an F’ episome encod- 
mg the lac Iq gene and the pro AB locus from E. coli strain HB2151 
was introduced by conjugation, yielding strain KM3. Strain KM3 was 
shown directly to lack fructose-l ,6-bisphosphate aldolase by appropri- 
ate enzyme assay. 
2.4. Purr$carion of Class II FBP-aldolase 
pKfda2 transformed E. co/r strain KM3 cells, grown in the presence 
of 0.3 mM ZnCl, and induced with 2 mM IPTG, were suspended in 
50 mM potassium phosphate buffer pH 7.0 and disrupted in a French 
Press at 4°C and cell pressure of 140 MPa. After centrifugatton 
(14.000 x g, 1 h). the 4&80%-saturation (NH,)$OI precipitate, which 
contained the enzyme activity, was collected and dissolved in 50 mM 
Tris-HCl buffer pH 8.0 and was dialysed against the same buffer. The 
enzyme was then applied to a DE52 column and, after washing with 
80 mM NaCl. the enzyme was eluted with 120 mM NaCl m the same 
buffer. Fractions containing the aldolase were pooled and concen- 
trated by precipitation with 80% saturation (NH&SO,. After dialysis 
against 100 mM Tris-HCl buffer pH 8.0 the enzyme was applied to 
a Superdex 200 column equilibrated with 100 mM Tris-HCl buffer pH 
8.0. The active peak fractions were pooled and the protein was judged 
to be homogeneous by SDS-PAGE. 
2.5. Other methods 
The native M, of the overexpressed E. co11 Class II FBP-aldolase 
was determined by gel-filtration FPLC on a Pharmacta Superose 12 
column in 50 mM potassium phosphate buffer pH 7.5. The subunit 
A4, was estimated by SDS-PAGE on 10% polyacrylamide slab gels 
1201. 
A coupled enzymic assay was used for FBP-aldolase [21]. The de- 
crease m A34,, m an assay containing fructose 1,6-bisphosphate (3 
mM), NADH (20 mM). coupling enzymes (2~1 ofa 10 mg/ml mixture 
of glycerol phosphate dehydrogenase/triose phosphate isomerase) and 
a suitable aliquot of the aldolase was measured in 50 mM Tris-HCl 
buffer pH 8.0 at 30°C. One unit of enzyme activity is defined as that 
causing the oxidation of 2 pmol of NADH/min in this assay. Kinetic 
parameters were estimated by non-linear regression analysis [22]. Pro- 
tem concentration was determined by the method of Bradford [23]. 
12 
Zinc was determined by atomic absorption spectrometry usmg a 
Perkin-Elmer model 380 atomic absorption spectrometer. Absorbance 
peak areas were measured at 213.9 nm. All values are the averages 01 
at least 10 readings. Dilutions were made with metal-free 100 mM 
Tris-HCI buffer, pH 8.0. The detection limit was about 0.5 x 1 O-’ M 
zinc. 
3. RESULTS AND DISCUSSION 
3.1. Overexpression, purl$cation and characterisation of 
the Class II FBP-aldolase from E. coli 
The original overexpression system for the E. coli fda 
gene (pKfda) [15] has been adapted to allow repeated 
directional subcloning between an Ml3 based mut- 
agenesis vector and the pKK223-3 based expression 
vector (Fig. 1). The new expression vector, pKfda2, can 
be efficiently transformed into the desirable fda- strain 
of E. coli, KM3 and the aldolase is expressed at ex- 
tremely high levels. The expression of the wild-type and 
mutant Class II aldolases was routinely carried out in 
cells grown in the presence of 0.3 mM ZnCl, to avoid 
the formation of inactive apoenzyme. 
The purified wild-type enzyme had the expected spe- 
cific activity of 6.1 U/mg and analysis by SDS-PAGE 
showed the preparation to be homogeneous. The amino 
acid composition of the purified enzyme was, within 
error, identical to that of the naturally expressed E. coli 
enzyme [24] and with that expected from the DNA se- 
quence of the fda gene [IS]. The N-terminal sequence, 
Ser-Lys-Ile-Phe-Asp, matched exactly the predicted se- 
quence except that the N-terminal methionine was ab- 
sent. Thus. despite the enormous overexpression, the 
enzyme is still efficiently processed in a manner identical 
to that of the naturally expressed protein [24]. The na- 
tive and subunit molecular weights of the overexpressed 
aldolase were determined as 78,000 Da and 39,000 Da, 
respectively. in excellent agreement with the predicted 
value of 39,016 Da and confirming that the overex- 
pressed protein correctly assembles into a dimer of iden- 
tical subunits [14.24,25]. The K, of the purified enzyme 
for fructose 1,6-bisphosphate was estimated to be 240 
,uM and agrees closely with that previously reported for 
the E. coli and other Class II enzymes [24,25]. Stimula- 
tion (2- to 35-fold) of the activity of Class II aldolases 
in Tris buffers by ca. 100 mM potassium ions has been 
reported [25]. As expected, at pH 8.0 in 50 mM Tris- 
HCI. the addition of 100 mM KC1 stimulated the over- 
expressed enzyme about threefold. Under these condi- 
tions, there is no significant change in the K, for FBP 
(Table I). 
3.2. Measurement of zinc and ident$cation of the zinc- 
binding ligands 
The zinc content of the overexpressed enzyme, meas- 
ured after gel filtration of the enzyme in metal-free 
buffer, was 2.3 + 0.2 zinc atoms per enzyme dimer (as- 
suming a subunit molecular weight of 39,000 Da) (Table 
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pKfda2 
5714 bp 
BamHl 
Hindlll 
Digest with JZcoRI and 
BamHl and ligate fcla 
gene into M13mp19 cut 
with the same nzymes. 
YlOfda .-- 
L Silent mutagenesis to remove internal HindIII site while leaving encoded sqJencetmafh!cted 
Digest with EcoRI and BindIII. 
Ligate into EcoRI/HindIII 
digested pKK223-3 
4 
Fig. 1. The construction of the expression vector pKfda2. Thefdu-containing fragment from pKfda [15] was subcloned into M 13mp19 RF 
Site directed mutagenesis was used to remove the internal Hind111 site, and the fda gene was cloned into pKK223-3 to yield the expression 
pKfda2. 
DNA. 
vector 
I), confirming that the holoenzyme contains a full com- 
plement of zinc ions. 
Comparison of the structures of a number of zinc- 
containing enzymes has revealed a zinc-binding motif 
[26]. In enzymes where zinc fulfills a catalytic role, the 
metal is usually tetrahedrally coordinated to 3 amino 
acid ligands and a water molecule. The binding motif 
consists of two amino acid ligands, L, and L?, separated 
Table I 
Kinetic parameters and zinc content of wild-type and mutant E. coli Class II FBP-aldolases 
Enzyme Buffer/Additions Specific activity 
Umg) 
Fold stimulation 
wnh K’ 
Km FBP 
01M) 
k Cd, 
(min-‘) 
Zn ions per 
enzyme dimer 
Wild-type 50 mM Tris-HCI pH 8.0 6.1 _ 240 + 30 620 f 18 2.3 + 0.2 
Wild-type Ditto + 100 mM 20.6 3.4 290 f 40 1,820 + 50 _ 
potassium acetate 
H108A 50 mM Tris-HCI pH 8.0 N.D. _ 0.13 + 0.01 
HlllA Ditto N.D. _ _ _ 0.15 + 0.01 
Cl 12A Ditto 1.9 _ 260 + 30 240 + 12 0.73 + 0.06 
H142A Ditto 4.7 _ 350 f 17 330+ 6 1.78 + 0.1 
The initial rates of reaction at various concentration of fructose 1,6-bisphosphate were measured by following the decrease in A,,, in a coupled 
assay system [21]. The kinetic parameters were estimated by non-linear regression analysis [22]. Zinc, protein concentration and enzyme activity 
were all determined as described in section 2. The zinc content per dimer was calculated based on a molecular weight of the enzyme subunit of 
39,016 Da. N.D., not detectable. 
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C.glutamicum 
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yeast 
C.glutamicum 
E.coli 
yeast 
C.glutamicum 
E.coli 
yeast 
C.glutamicum 
E.coli 
Yeast 
C.glutamicum 
E.coli 
Yeast 
C.glutamicum 
E.coli 
Yeast 
C.glutamicum 
E.coli 
yeast 
C.glutamicum 
1 
MSKIFDFVK PGVITGDDVQ KVFQVAKENN 
MGVEQILKRK TGVIVGEDVH NLFTYAKEHK 
PIATPEVYN EMLDRAKEGG 
51 
50 
FALPAVNCVG TDSINAVLET 
FAIPAINVTS SSTAVAALEA 
FAFPAINCTS SETINAALKG 
100 
AAKVKAPVIV QFSNGGASFI AGKGVKSDVP QGAAILGAIS GAHHVHQMAJZ 
ARDSKSPIIL QTSNGGAAYF AGKGI.SNEG QNASIKGAIA AAHYIRSIAP 
FAEAESDGII QFSTGGAEFG SGLAVKNKVK . . . . ..GAVA LAAFAHEAAK 
101 150 
HYGVPVILHT DIi0KKLL.P WIDGLLDAGE KHFAATGKPL FSSHMIDLSE 
AYGIPVVLHS DIiCAKKLL.P WFDGMLEADE AYFKEHGEPL FSS&dLDLSE 
SYGINVALHT DHCQKEVLDE YVRPLLAISQ ERVDRGELPL FQSEMWDGSA 
===z= ==I= 
151 200 
ESLQENIEIC SKYLERMSKI GMTLEIELGC TGGEEDGVDN SHMDASALYT 
ETDEENISTC VKYFKRMAAM DQWLEMEIGI TGGEEDGVNN ENADKEDLYT 
VPIDENLEIA QELLAKAKAA NIILEVEIGV VGGEEDGVEA ..KAGANLYT 
==== -_=t 
201 250 
QPEDVDYAYT ELSK.ISPRF TIAASFGNVX GVYKPGNVVL TPTILRJJSQE 
KPEQVYNVYK AL.HPISPNF SIAAAFGNCH GLY.AGDIAL RPEILAEHQK 
SPEDFEKTID AIGTGEKGRY LLAATFGNVE GVYKPGNVKL RPEVLLEGQQ 
251 300 
YVSKKHN.LP HN.SLNFVFii GGSGSTAQEI KDSVSYGWK MNIDTDTQWA 
YTREQVGC.K EEKPLFLVFH GGSGSTVQEF HTGIDNGVVK VNLDTDCQYA 
VARKKLGLAD DALPFDFVFB GGSGSEKEKI EEALTYGVIK MNVDTDTHYA 
301 350 
TWEGVLNYY KANEAYLQGQ LGNPKGEDQP NKKYYDPRVW LRAGQTSMIA 
Y.LTGIRDYV LNKKDYIMSP VGNPEGPEKP NKKFFDPRVW VREGEKTMGA 
FTRPIVSHMF ENYNGVLK.. . . ..IDGEVG NKKAYDPRSY MKKAEQSMSE 
351 368 
RLEKAFQELN AIDVL... 
KITKSLETFR TTNTL... 
RIIESCQDLK SVGKTTSK 
Fig. 2. Alignment of the primary sequences of the Class II FBP-aldolases from E. roll, C glutamicum and yeast. The primary sequences for the 
fructose- I ,6-bisphosphate aldolases from E. coli [IS], S. cererrskze [32] and C glutumicum [33] were aligned using the computer program GAP [34] 
with a gap weight of 3.0 and a gap length weight of 0.1. The five regions of the proteins where conserved histidine. cysteine, glutamic acid or aspartic 
acid residues are found in positions which align with the observed L,. LZ, L, hgand pattern [26] and hence might act as the zinc-binding ligands 
are shown underlined. 
by 1-3 amino acids and a third amino acid ligand, L,, 
separated from the other two by either about 20 or 
about 120 amino acids. The predominant amino acid 
ligand in these enzymes is histidine, with much lower 
frequencies of glutamic acid, aspartic acid and cysteine. 
We used the L,, L,, L, pattern described above to search 
for a potential zinc-binding site in the E. coli Class II 
aldolase. This approach has been successfully used even 
when, as in this case, the degree of identity between the 
primary sequences of the unknown structure and any of 
the known ones is low (<20%) [27]. Residues important 
in zinc binding were presumed to be conserved in the 
Class II aldolases and the search therefore focussed on 
conserved histidine, cysteine, glutamic and aspartic acid 
residues. An alignment of the primary sequences of the 
Class II aldolases from E. coli, C. glutumicum and S. 
cerevisiae is shown in Fig. 2. There are five regions 
where conserved residues are suitably positioned to act 
as the L, and L, ligands (Fig. 2). Only two of these 
regions contain histidine, the most likely of which 
would be that encompassing residues 108 and 111 since 
14 
it uniquely contains two conserved histidine residues. 
This section of polypeptide (His-Thr-Asp-His-Cys) also 
includes the only conserved cysteine residue (Fig. 2). In 
addition, 32 residues nearer the C-terminus there is a 
third conserved histidine residue (His-142) which could 
act as L,. Residues His-108. His-l 11, Cys-112 and His- 
142 were, therefore, each changed to alanine. 
All the mutant proteins were expressed in E. co/i 
strain KM3 and purified as described for the wild-type 
enzyme. All were dimeric proteins with the correct sub- 
unit molecular weights. The close similarity of the far 
UV CD spectra of the mutant and wild-type proteins 
(Fig. 3) indicates that no major structural changes result 
from the mutations. The mutants H108A and Hl 11A 
contained very low levels of zinc and were virtually 
inactive (Table I). Addition of an excess of zinc (up to 
lOO-fold) did not result in an increase in activity. Clearly 
His-108 and His-l 11 are two of the zinc-binding li- 
gands. The concomitant loss of enzyme activity and zinc 
content in these mutants confirms the essential role of 
zinc in catalysis. By contrast, the contribution of zinc 
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Fig. 3. Far UV Circular dichroism spectra of wild-type and mutant 
Class II aldolases. The far UV circular dichroism spectra of wild-type 
and mutant Class II FBP-aldolases (ca. 1 mg/ml) in 20 mM potassium 
phosphate buffer pH 7.6 were measured on a Jobin Yvon CD6 instru- 
ment in a cell with pathlength 0.1 mm. Spectra were smoothed using 
the Sabitzky Golay algorithm using a sliding average over 7.5 nm. The 
exact concentration of each enzyme was determined by amino acid 
analysis. Wild-type (-); Hl08A mutant (---_); HlllA mutant 
(-,-.); Cl 12A mutant (-...-); Hl42A mutant (......). 
to the maintenance of tertiary structure must be very 
limited (Fig. 3). Such a His-X-X-His motif is also found 
in the related Class II enzyme fuculose-l-phosphate al- 
dolase [28] and in the cfxA gene tentatively identified as 
a Class II FBP-aldolase in Rhodobacter sphaeroides [29] 
and should be a strong candidate for zinc binding in 
these enzymes. 
In contrast to mutations H 108A and H 111 A, the mu- 
tant H142A was found to have a specific activity of 4.7 
units/mg protein and a zinc content of 1.78 zinc ions per 
dimer (Table I). Substituting His-142 by alanine had 
little effect on the kinetic parameters of the enzyme 
(Table I). On transfer of this enzyme into metal-free 
buffer, the enzyme activity and the zinc content fell to 
almost zero. Addition of excess zinc to this inactive 
enzyme resulted in restoration of the original specific 
activity and a maximum zinc content of 1.8 ions per 
dimer. His-142, therefore is unlikely to be the third zinc- 
binding ligand. It may be, however, that His-142 is a 
weak, but direct ligand to the zinc ion, alternatively, the 
effect of its mutation might be via a local change in the 
zinc-binding site. 
It has previously been suggested [30.31] that cysteine 
groups might be important for zinc-binding in the yeast 
Class II aldolase. Only one cysteine residue, Cys-112, is 
conserved in the three Class II enzymes (Fig. 2) and thus 
this residue was mutated to an alanine residue. The 
resulting protein (Cl 12A) had a specific activity of only 
1.9 U/mg, about 30% of the wild-type activity (Table I). 
Similarly, a zinc content of 0.7 Zn per dimer (Table I) 
was observed. The addition of excess zinc (up to lOO- 
fold) did not result in any increase in activity. Mutation 
of Cys-112 does not, therefore, totally abolish zinc bind- 
ing as would be expected for a direct metal-binding 
ligand [27]. The kinetic parameters for this enzyme were 
also similar to those of the wild-type enzyme (Table I). 
The lower zinc content in this mutant enzyme may re- 
sult from the close proximity of Cys-112 to His-l 11, a 
residue already identified as a ligand to the zinc ion (see 
above). Mutation of such a close neighbour could cause 
localised changes resulting in a more unfavourable envi- 
ronment for zinc binding. That any such changes can- 
not be a consequence of major changes in structure can 
be seen from the similarity of the far UV CD spectrum 
of the Cl 12A mutant to the wild-type enzyme (Fig. 3). 
The present study has shown that the pKfda2 expres- 
sion system can be used efficiently to produce large 
amounts of the E. coli FBP-aldolase. By sequence align- 
ments, putative zinc ligands in the enzyme were pin- 
pointed (Fig. 2) and have been individually mutated. 
Two ligands, His-108 and His-l 11, have been identified 
unequivocally as zinc-binding ligands. Residue His-142, 
which is at an appropriate distance in the primary se- 
quence to act as the L, ligand [26] does not appear to 
be a direct zinc-binding ligand. Similarly, the only con- 
served cysteine residue, Cys-112, does not appear to be 
directly involved in zinc binding. Mutation of these res- 
idues may disrupt the environment of the zinc-binding 
site without their being direct ligands. The role of the 
other 2 conserved histidine residues (Fig. 2) and the 
identity of the L, ligand in the E. cofi Class II aldolase 
will have to await further site-directed mutagenesis ex- 
periments. 
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